Zuoyi Jiao
Impact in
-
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Ubiquitin and proteasome pathways 4
- Cancer-related gene regulation 3
- Glycosylation and Glycoproteins Research 2
- Oncology 10
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 3
- Co-authors
- Shuang‐Jiang Liu (1 shared paper)Xiangkai Li (1 shared paper)Weilin Jin (1 shared paper)Jing Ji (1 shared paper)Xiaoying Guan (6 shared papers)Yumin Li (6 shared papers)Huinian Zhou (11 shared papers)Wenting He (2 shared papers)
- Journals
- Cancer Research (3 papers)Oncogene (2 papers)Materials Today Bio (2 papers)Oncology Reports (1 paper)Cancer Management and Research (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Zuoyi Jiao
34 papers receiving 863 citations
Zuoyi Jiao's Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 112
- Oncology 168
- Molecular Biology 441
- Immunology 115
- Biological Psychiatry 12
Countries citing papers authored by Zuoyi Jiao
This map shows the geographic impact of Zuoyi Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuoyi Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuoyi Jiao more than expected).
Fields of papers citing papers by Zuoyi Jiao
This network shows the impact of papers produced by Zuoyi Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuoyi Jiao. The network helps show where Zuoyi Jiao may publish in the future.
Co-authors
The 25 scholars most cited alongside Zuoyi Jiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Probiotics, prebiotics, and postbiotics in health and disease Hit paper breakdown → | 2023 | 233 |
| 2 | 2018 | 132 | |
| 3 | 2020 | 84 | |
| 4 | 2020 | 64 | |
| 5 | 2023 | 63 | |
| 6 | 2021 | 61 | |
| 7 | 2013 | 38 | |
| 8 | 2019 | 28 | |
| 9 | 2022 | 26 | |
| 10 | 2007 | 17 | |
| 11 | 2020 | 12 | |
| 12 | 2023 | 11 | |
| 13 | 2019 | 10 | |
| 14 | 2019 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2022 | 8 | |
| 17 | 2012 | 8 | |
| 18 | 2023 | 7 | |
| 19 | 2020 | 6 | |
| 20 | 2025 | 6 |
About Zuoyi Jiao
Zuoyi Jiao is a scholar working on Molecular Biology, Oncology, Cell Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 36 papers that have together received 876 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Microtubule and mitosis dynamics (4 papers), Immune cells in cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer-related gene regulation (3 papers), CAR-T cell therapy research (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Cancer Research (112 citations), Oncology (168 citations), Molecular Biology (441 citations), Immunology (115 citations) and Biological Psychiatry (12 citations). Zuoyi Jiao has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Shuang‐Jiang Liu, Xiangkai Li, Weilin Jin, Jing Ji, Xiaoying Guan, Yumin Li, Huinian Zhou, Wenting He, Xiangyan Jiang and Hao Chen. Their work appears in journals such as Cancer Research, Oncogene, Materials Today Bio, Oncology Reports and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.